A drug approved to treat cancer could change the course of medicine. Recent studies have shown that this drug can reactivate up to 90% of HIV-infected cells that remain dormant in the body, allowing the immune system or targeted treatments to eliminate them. This finding opens the door to a possible definitive eradication of the virus, although further research and clinical trials are still needed to confirm its effectiveness in human patients.

Since its discovery in the 1980s, HIV has been one of the greatest challenges for the medical community. Although antiretroviral treatments have significantly improved patients' quality of life and reduced viral load to undetectable levels, the virus remains hidden in cellular reservoirs, preventing its complete elimination from the body. This new drug, by activating these "dormant" cells, could allow for the total elimination of the virus, bringing us closer to a possible cure.

Clinical trials are ongoing to evaluate the safety and efficacy of this treatment in humans. If the results continue to be promising, it could mark a milestone in medicine and change the course of the fight against HIV.